Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 3
Submit an article Journal homepage
3,265
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials

Ralf E. Harskampa Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Academic Medical Center, AZ Amsterdam, The Netherlands;b Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9041-0350View further author information
ORCID Icon,
Wim A.M Lucassena Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Academic Medical Center, AZ Amsterdam, The NetherlandsView further author information
,
Renato D. Lopesb Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USAView further author information
,
Jelle C.L Himmelreicha Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Academic Medical Center, AZ Amsterdam, The NetherlandsView further author information
,
Gianfranco Paratic IRCCS Instituto Auxologico Italiano and Department of Medicine and Surgery, University of Milano-Bicocca, Milan, ItalyView further author information
&
Henk C.P.M van Weerta Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Academic Medical Center, AZ Amsterdam, The NetherlandsView further author information
Pages 191-195 | Received 27 Nov 2020, Accepted 22 Jan 2021, Published online: 08 Mar 2021

References

  • Staerk L, Wang B, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018;361:k1453
  • Liatakis I, Manta E, Tsioufis C. Hypertension and atrial fibrillation: epidemiological data, pathogenesis, and therapeutic implications. Am J Hypertens. 2019;32(8):725–726.
  • Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res. 2018;122(2):352–368.
  • Rao MP, Halvorsen S, Wojdyla D, et al. Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. J Am Heart Assoc. 2015;4(12):e002015.DOI:https://doi.org/10.1161/JAHA.115.002015
  • Nagarakanti R, Wallentin L, Noack H, et al. Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY Trial). Am J Cardiol. 2015;116(8):1204–1209.
  • Park S, Bergmark BA, Shi M, et al. Edoxaban versus warfarin stratified by average blood pressure in 19 679 patients with atrial fibrillation and a history of hypertension in the ENGAGE AF-TIMI 48 trial. Hypertension. 2019;74(3):597–605.
  • Vemulapalli S, Hellkamp AS, Jones WS, et al. Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: results from the ROCKET AF Trial. Am Heart J. 2016;178:74–84.
  • Matsumoto M, Hori M, Tanahashi N, J-ROCKET AF Study Investigators, et al. Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial. Hypertens Res. 2014;37(5):457–462.
  • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272.
  • Esteve-Pastor MA, Rivera-Caravaca JM, Lip GYH. Hypertension and atrial fibrillation: balancing stroke and bleeding risks. Am J Hypertens. 2017;30(11):1063–1065.
  • Dzeshka MS, Shantsila A, Shantsila E, et al. Atrial fibrillation and hypertension. Hypertension. 2017;70(5):854–861.
  • Williams B, Mancia G, Spiering W, List of authors/Task Force members, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284–2309.
  • Lip GY, Frison L, Grind M, on behalf of the SPORTIF Investigators, et al. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J. 2007;28(6):752–759.
  • Kim D, Yang PS, Kim TH, et al. Ideal blood pressure in patients with atrial fibrillation. J Am Coll Cardiol. 2018;72(11):1233–1245.
  • Parkash R, Wells GA, Sapp JL, et al. Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]). Circulation. 2017;135(19):1788–1798.
  • Rienstra M, Hobbelt AH, Alings M, for the RACE 3 Investigators, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;39(32):2987–2996.
  • Arima H, Hart RG, Colman S, PROGRESS Collaborative Group, et al. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke. 2005;36(10):2164–2169.
  • Investigators AI, Yusuf S, Healey JS, et al. Irbesartan in patients with atrial fibrillation. N Engl J Med. 2011;364(10):928–938.
Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.